ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

ASCO, NCCN Develop Quality Measures For Cancer Care

August 25, 2006

Reauthorization Still Held up

September 30, 1988